Skip to main content

COVID-19 and Cancer Consortium Archives

Black patients with cancer face worse COVID outcomes: study

Mar. 31, 2022—Vanderbilt researchers have found that Black patients with cancer experienced significantly worse outcomes after COVID-19 diagnosis than non-Hispanic white cancer patients.

Read more


COVID-19 and Cancer Consortium study highlights racial disparities, increased mortality for patients facing dual diagnoses

Mar. 19, 2021—The COVID-19 and Cancer Consortium (CCC19) published new findings in the Annals of Oncology showing heightened mortality and racial disparities for patients with cancer diagnosed with SARS-CoV-2 infection.

Read more


New data offer insights on COVID treatments for people with cancer

Jul. 22, 2020—Newly released data on treatment outcomes of people with cancer diagnosed with COVID-19 reveal a racial disparity in access to Remdesivir, an antiviral drug that has been shown to shorten hospital stays, and increased mortality associated with dexamethasone, a steroid that has had the opposite effect in the general patient population.

Read more


Initiative to explore COVID-19 outcomes in cancer patients

Apr. 30, 2020—A multi-institutional consortium led by Vanderbilt-Ingram Cancer Center (VICC) is collecting data on cancer patients with COVID-19 as part of a rapid effort to understand the unique effects the coronavirus has on this vulnerable population.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more